SOURCE: Equity News Circuit
NEW YORK, NY--(Marketwire - Nov 23, 2012) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
Alcatel Lucent SA (NYSE: ALU) shares of the communications equipment company have fallen sharply this past week after reporting its second consecutive quarterly loss. Alcatel-Lucent announced 5,500 job cuts in October, and more may be on the way for the struggling company.
Find out more about Alcatel Lucent including full access to the free equity report at: www.BedfordReport.com/ALU
Apricus Biosciences Inc. (NASDAQ: APRI) shares declined nearly 30 percent in the past month. The biotech company has recently announced that Bassam Damaj, Ph.D., has resigned as a Director, President, and Chief Executive Officer of the company.
Find out more about Apricus Biosciences including full access to the free equity report at: www.BedfordReport.com/APRI
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares of anti-obesity drug maker have gained nearly 400 percent year-to-date. Eisai Co., Ltd., who will market Belviq in the U.S., expects the weight loss drug to reach the U.S. market in early 2013.
Find out more about Arena Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/ARNA
Vringo, Inc. (NYSE: VRNG) shares of the mobile software company have soared over 275 percent year-to-date. The company has recently filed a patent infringement lawsuit against the UK subsidiary of ZTE Corporation.
Find out more about Vringo including full access to the free equity report at: www.BedfordReport.com/VRNG
Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.